Weight Loss Injections and Skin Side Effects | Dermatology Guide

Weight loss injections such as semaglutide (Wegovy®, Ozempic®) and tirzepatide (Mounjaro®, Zepbound®) have become increasingly popular treatments for obesity and metabolic disease. These medications belong to a class known as GLP-1 receptor agonists, which work by reducing appetite, slowing stomach emptying, and improving blood sugar control.

For many people, these medications can lead to significant weight loss and improvements in overall health. However, as with all medications, side effects can occur, including some that affect the skin, hair, and appearance.

This article explains the dermatology-related effects associated with weight loss injections, based on current medical research.

1. Hair Loss (Alopecia)

One of the most frequently reported dermatological concerns with GLP-1 medications is hair loss.

Research suggests this is usually due to telogen effluvium, a temporary form of hair shedding triggered by physiological stress such as rapid weight loss or nutritional changes. Rapid weight loss can push hair follicles prematurely into the resting phase of the hair cycle, resulting in noticeable shedding several months later.

Other factors that may contribute include:

• Reduced calorie intake

Reduced calorie intake

• Nutritional deficiencies (such as iron, zinc or protein)

Nutritional deficiencies (such as iron, zinc or protein)

• Physiological stress associated with significant weight loss

Physiological stress associated with significant weight loss

Importantly, this type of hair loss is usually temporary, and hair often regrows once weight stabilises and nutrition improves.

Hair loss is a common side effect of weight loss jabs

2. Skin Rashes and Hypersensitivity Reactions

Although uncommon, some patients may experience skin rashes or allergic-type reactions while taking GLP-1 medications.

Reported reactions include:

• Urticaria (hives)

Urticaria (hives)

• Drug eruptions

Drug eruptions

• Generalised itching

Generalised itching

• Hypersensitivity reactions

Hypersensitivity reactions

These reactions are typically rare but should be assessed by a clinician, particularly if they are persistent or worsening.

3. Injection-Site Reactions

Because these medications are injected weekly, local skin reactions can occur at the injection site.

Symptoms may include:

• Redness
• Mild swelling

Mild swelling

• Itching
• Tenderness or small nodules

Tenderness or small nodules

Most injection-site reactions are mild and temporary, and they often improve by rotating injection sites and using proper injection technique.

4. Rapid Weight Loss and Skin Changes (“Ozempic Face”)

Many patients notice changes in facial appearance during rapid weight loss. In the media this has been referred to as “Ozempic face.”

This is not a direct drug reaction, but rather the result of:

• Loss of subcutaneous fat

Loss of subcutaneous fat

• Reduced facial volume

Reduced facial volume

• Skin laxity

Skin laxity

• Increased visibility of wrinkles

Increased visibility of wrinkles

Rapid fat loss can sometimes outpace the skin’s ability to tighten and adapt, particularly in individuals over 40 or those with significant weight loss.

Dermatologists may recommend treatments such as:

• Skin-quality treatments

Skin-quality treatments

• Collagen-stimulating procedures

Collagen-stimulating procedures

• Dermal fillers (in appropriate cases)

Dermal fillers (in appropriate cases)

• Medical skincare

Medical skincare

Rapid weight loss can result in sagging skin

5. Rare Autoimmune Skin Conditions

Rarely, GLP-1 medications have been associated with immune-mediated skin disorders, including:

• Bullous pemphigoid (an autoimmune blistering disease)

Bullous pemphigoid (an autoimmune blistering disease)

• Angioedema
• Severe hypersensitivity reactions

Severe hypersensitivity reactions

These conditions are extremely uncommon but require urgent medical assessment if symptoms such as blistering or facial swelling occur.

6. Why Dermatology Monitoring Matters

GLP-1 medications are increasingly used for both diabetes and weight management, meaning millions of patients worldwide are now taking them. As their use increases, dermatologists are recognising a broader spectrum of skin-related effects.

While most reactions are mild and manageable, clinicians should monitor for:

• Hair shedding

Hair shedding

• Persistent rashes

Persistent rashes

• Injection-site reactions

Injection-site reactions

• Significant changes in skin quality

Significant changes in skin quality

Early recognition ensures patients can receive appropriate treatment and reassurance.

When Should You Seek Medical Advice?

You should contact your clinician if you experience:

• Sudden or severe hair loss

Sudden or severe hair loss

• Persistent rash or itching

Persistent rash or itching

• Swelling of the face, lips or eyes

Swelling of the face, lips or eyes

• Blistering or painful skin lesions

Blistering or painful skin lesions

• Injection-site reactions that worsen or do not improve

Injection-site reactions that worsen or do not improve

Never stop prescribed medication without speaking to your healthcare provider.

Final Thoughts

Weight loss injections can be highly effective treatments for obesity and metabolic health. However, patients should be aware that skin and hair changes can occur, particularly during periods of rapid weight loss.

Most dermatological effects are temporary or manageable, but awareness is important so that patients and clinicians can address concerns early.

If you are considering weight loss medication or have concerns about side effects, speak to a qualified healthcare professional who can assess your individual health and treatment options.

To book an appointment with our dermatology team,

Call: 01638 491074

Book online: https://www.medicalskinclinic.co.uk

References

• Burke et al. Alopecia and Semaglutide: Connecting the Dots for Patient Safety. Journal of Cosmetic Dermatology.
• Hidayat et al. Dermatologic Implications of Glucagon-Like Peptide-1 Receptor Agonists. Skin Appendage Disorders.
• American Academy of Dermatology literature review: Impact of GLP-1 receptor agonists on cutaneous events.
• Hearn EB, Sherman JJ. Injection-site reactions with GLP-1 receptor agonists. American Academy of Allergy, Asthma & Immunology.
• Dermatology Times. New analysis clarifies dermatologic risks of GLP-1 receptor agonists.
• Dermatologic reviews on GLP-1 medications and skin effects.
• Dermatology literature discussing facial volume loss during GLP-1 weight loss therapy.